Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | GSK3A | P49840 | 2/20 | 0.32 |
| ▸ | GSK3B | P49841 | 2/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.31 |
| ▸ | CASP7 | P55210 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ADK | P55263 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2704330 | 0.85 | CASP3 (0.35) | CASP3MAPTGSK3AGSK3BMGLL | |
| SCHEMBL10137978 | 0.84 | MAPT (0.32) | CASP3MAPT | |
| SCHEMBL8607136 | 0.82 | MAPT (0.32) | CASP3MAPT | |
| SCHEMBL17190540 | 0.78 | MAPT (0.32) | CASP3MAPT | |
| SCHEMBL15031169 | 0.77 | CASP3 (0.34) | CASP3MAPT | |
| SCHEMBL17427805 | 0.77 | — | — | |
| SCHEMBL17897616 | 0.77 | MAPT (0.33) | CASP3MAPTKMT2A | |
| SCHEMBL14444942 | 0.75 | MEN1 (0.34) | CASP3MAPTMEN1USP2CASP1 | |
| SCHEMBL18405814 | 0.73 | MAPT (0.30) | CASP3MAPT | |
| SCHEMBL8374335 | 0.73 | PRKCA (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140154815-A1 | Luminescent Compounds, Complexes and Their Uses | LONDON METROPOLITAN UNIVERSITY (GB) | 2014-06-05 | — | — | US | disclosed |
| US-20120302704-A1 | COPOLYMER COMPOSED OF A POLYPHENYLENE AND A FLEXIBLE CHAIN COMPONENT | ROBERT BOSCH GMBH (DE) | 2012-11-29 | — | — | US | disclosed |
| US-7531664-B2 | Flame retarding compounds | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2009-05-12 | — | — | US | disclosed |
| US-20080139707-A1 | Multi-Color Coloring Laser Marking-Use Chromatic Color Colorant, Multi-Color Coloring Laser Marking-Use Composition And Molding Containing It, Multi-Color Making-Carrying Molding And Laser Marking Method | TECHNO POLYMER CO., LTD. (JP) | 2008-06-12 | — | — | US | disclosed |
| US-7385064-B1 | Catalysts for use in enantioselective synthesis | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK | 2008-06-10 | — | — | US | disclosed |
| US-20080050663-A1 | Laminate for laser marking | TECHNO POLYMER CO., LTD. (JP) | 2008-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140154815-A1 | Luminescent Compounds, Complexes and Their Uses | PML, UACA, TBC1D5 | CASP3 262/4885MAPT 512/4885GSK3A 4839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.